| abstract |
[PROBLEMS] To provide an IL-2 production inhibitor, an agent for preventing or treating an allergic, inflammatory, or autoimmune disease. Use of a calcium release-dependent calcium channel inhibitor characterized by containing a pyrazole derivative or a pharmaceutically acceptable salt thereof (The symbols in the formula represent the following meanings: B: divalent group of a monocyclic aromatic heterocyclic ring which may be substituted with phenylene or lower alkyl, X: -NR 1 -CO-, -CO-NR 1 -, -NR 1 -S O 2 -or -SO 2 -NR 1 -Y: a bond, -CO-, -lower alkylene-, or -lower alkenylene-, A: a substituent selected from -OH, -O-lower alkyl and -F A phenyl having at least one or a monocyclic or bicyclic or tricyclic fused heteroaryl which may have a substituent; ) |